Africa & Middle East

The laboratory serves as the country’s primary reference centre for sophisticated testing, disease investigation, genetic analysis, and quality control across all health facilities.

This partnership with Novartis creates a vital platform to increase awareness of chronic urticaria among dermatologists and other healthcare professionals.

This new division integrates operations from 16 hospitals, numerous primary care clinics, and state-of-the-art laboratories.

The hospital’s expanded referral network encompasses Nyeri, Murang’a, Embu, Karatina, Isiolo, Marsabit, Meru, Tharaka-Nithi, Samburu, Nanyuki, and Kirinyaga counties.

The residency program prepares nurses for advanced clinical practice in Adult Critical Care through a curriculum that aligns with national regulatory requirements and international best practices.

Inpefa is the first dual SGLT1 and SGLT2 inhibitor approved specifically for heart failure treatment.

The newly acquired state-of-the-art technology empowers surgeons to examine and treat internal organs through a minimally invasive approach that transforms traditional surgical procedures.

The government has fully funded the first phase of the vaccine manufacturing facility, which has already reached completion.

The Advisory Board will play a central role in steering the strategic direction of the Pura Longevity Clinic, PureHealth’s pioneering center focused on personalized health longevity and precision medicine.

The program will also work to increase access to chemotherapy and provide essential emotional support services for patients navigating their cancer journey.